Cardiff-based biotech company Jellagen is receiving an injection of £8.7 million in investment from Thai Union and other strategic financial partners to continue development of collagen biomaterials derived from jellyfish.
Jellagen aims to revolutionise regenerative medicine through a range of medical devices and culture applications. Early clinical findings from Jellagen’s studies prove Collagen Type 0, derived from jellyfish, to be superior to mammalian counterparts, especially in medical and healing area...
(More Info)